Improving 3D scanning technology to understand the effects of obesity
Advancing 3D optical body surface scan technology to assess physiological and psychological effects in highly obese population
This study is looking to improve a special 3D scanning technology to help understand how obesity affects both the body and mind, especially for those with severe obesity, so we can find better ways to measure health risks and support treatment.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | George Washington University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-10903986 on NIH RePORTER |
What this research studies
This research focuses on enhancing 3D optical body surface scanning technology to better assess both the physiological and psychological impacts of obesity, particularly in individuals with severe obesity. The project aims to develop non-invasive and cost-effective methods to measure health risks associated with obesity, moving beyond traditional metrics like BMI. By utilizing advanced imaging techniques, the study seeks to provide more accurate assessments of body composition and self-perception, which are crucial for effective treatment and management of obesity-related conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with severe obesity, particularly those considering or undergoing bariatric surgery.
Not a fit: Patients with mild obesity or those who do not have any obesity-related health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and less invasive methods for assessing obesity-related health risks, ultimately improving patient care and treatment outcomes.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for health assessments, suggesting that this approach could yield valuable insights.
Where this research is happening
Washington, United States
- George Washington University — Washington, United States (Active)
Researchers
- Principal investigator: Hahn, James K — George Washington University
- Study coordinator: Hahn, James K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.